News on Acorda Therapeutics from BioPortfolio.com http://www.BioPortfolio.com Consolidated Acorda Therapeutics news from BioPortfolio.com Wed, 10 Feb 2010 04:25:08 GMT en Acorda Sets Ampyra Price Above Estimates, Reaps Benefit Of Clean Labelinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028454&HITNO=0&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028454&THISHREF=http://c.moreover.com/click/here.pl%3fz2532725134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028454&HITNO=0&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028454&THISHREF=http://c.moreover.com/click/here.pl%3fz2532725134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comThe Pink Sheet: Acorda Therapeutics Announces FDA Approval of AMPYRA(TM) dalfampridine to Improve Walking in People with Multihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018719&HITNO=1&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018719&THISHREF=http://c.moreover.com/click/here.pl%3fz2525905269%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018719&HITNO=1&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018719&THISHREF=http://c.moreover.com/click/here.pl%3fz2525905269%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Hapoalim Securities Reiterates a 'Buy' on Acorda (ACOR); Premium Ampyra Pricinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021092&HITNO=2&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021092&THISHREF=http://c.moreover.com/click/here.pl%3fz2527109817%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021092&HITNO=2&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021092&THISHREF=http://c.moreover.com/click/here.pl%3fz2527109817%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Acorda Therapeutics Announces Pricing and Patient Assistance Prog...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004540&HITNO=3&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004540&THISHREF=http://c.moreover.com/click/here.pl%3fz2520010030%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004540&HITNO=3&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004540&THISHREF=http://c.moreover.com/click/here.pl%3fz2520010030%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004302&HITNO=4&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004302&THISHREF=http://c.moreover.com/click/here.pl%3fz2519886916%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004302&HITNO=4&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004302&THISHREF=http://c.moreover.com/click/here.pl%3fz2519886916%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Acorda Therapeutics to Present at the 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005700&HITNO=5&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005700&THISHREF=http://c.moreover.com/click/here.pl%3fz2520440314%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005700&HITNO=5&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005700&THISHREF=http://c.moreover.com/click/here.pl%3fz2520440314%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA(TM) (dalfampridine)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004398&HITNO=6&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004398&THISHREF=http://c.moreover.com/click/here.pl%3fz2519932436%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004398&HITNO=6&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004398&THISHREF=http://c.moreover.com/click/here.pl%3fz2519932436%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004292&HITNO=7&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004292&THISHREF=http://c.moreover.com/click/here.pl%3fz2519879595%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004292&HITNO=7&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004292&THISHREF=http://c.moreover.com/click/here.pl%3fz2519879595%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Acorda Therapeutics Announces Pricing and Patient Assistance Programs for Ampyra (dalfampridine)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005099&HITNO=8&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005099&THISHREF=http://c.moreover.com/click/here.pl%3fz2520218053%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005099&HITNO=8&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005099&THISHREF=http://c.moreover.com/click/here.pl%3fz2520218053%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004396&HITNO=9&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004396&THISHREF=http://c.moreover.com/click/here.pl%3fz2519929363%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004396&HITNO=9&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004396&THISHREF=http://c.moreover.com/click/here.pl%3fz2519929363%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004368&HITNO=10&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004368&THISHREF=http://c.moreover.com/click/here.pl%3fz2519922064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004368&HITNO=10&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004368&THISHREF=http://c.moreover.com/click/here.pl%3fz2519922064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA(TM) (dalfampridine)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004417&HITNO=11&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004417&THISHREF=http://c.moreover.com/click/here.pl%3fz2519945275%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004417&HITNO=11&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004417&THISHREF=http://c.moreover.com/click/here.pl%3fz2519945275%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004276&HITNO=12&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004276&THISHREF=http://c.moreover.com/click/here.pl%3fz2519876616%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004276&HITNO=12&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004276&THISHREF=http://c.moreover.com/click/here.pl%3fz2519876616%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: AMPYRA for MS: Acorda Therapeutics announces wholesale pricing and patient assistance programhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004441&HITNO=13&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004441&THISHREF=http://c.moreover.com/click/here.pl%3fz2519964198%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004441&HITNO=13&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004441&THISHREF=http://c.moreover.com/click/here.pl%3fz2519964198%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Acorda Therapeutics Announces Pricing and Patient Assistance Programs for Ampyra (dalfampridine)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004995&HITNO=14&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004995&THISHREF=http://c.moreover.com/click/here.pl%3fz2520189129%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004995&HITNO=14&MSIZE=356&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Acorda%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004995&THISHREF=http://c.moreover.com/click/here.pl%3fz2520189129%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: